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Endobronchial ultrasound-guided transbronchial needle aspiration in patients presented with 
superior vena cava syndrome
M Wong, TT Tam, DC Lam, MS Ip, JC Ho
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
Background: Expedient pathological diagnosis is crucial in selection of appropriate treatment in patients 
presented with superior vena cava syndrome (SVCS). The performance and safety of endobronchial ultrasound-
guided transbronchial needle aspiration (EBUS-TBNA) in this setting is unknown. 
Methods: Over a 4-year period, patients presented with SVCS in the presence of mediastinal mass and referred 
for EBUS-TBNA were enrolled for the study. The procedure was performed under local anaesthesia with 
conscious sedation. TBNA was performed under real-time with the curvilinear probe of EBUS. Rapid on site 
cytological examination (ROSE) was not available. 
Results: Eighteen procedures of EBUS-TBNA were performed in 17 patients. Malignancy was confirmed in 
16 patients (diagnostic yield, 94.1%). There was no major complication including significant bleeding or 
pneumothorax related to the procedures. 
Conclusions: EBUS-TBNA has high diagnostic yield and is safe in patients presented with SVCS and mediastinal 
mass.
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Serum adiponectin in relation to other obesity-related biomarkers in predicting type 2 
diabetes: a 5-year prospective study
YC Woo1, AWK Tso1, A Xu1, LSC Law1, TH Lam2, SV Lo3, NMS Wat1, BMY Cheung1, KSL Lam1
Departments of 1Medicine and 2Community Medicine, The University of Hong Kong, Hong Kong
3Hospital Authority, Hong Kong
Aims: To identify obesity-related serum biomarkers associated with the development of type 2 diabetes in a 
Chinese population and to examine if these biomarkers added values to conventional risk factors in diabetes 
prediction.
Methods: We studied 1315 non-diabetic subjects from the prospective Hong Kong Cardiovascular Risk Factor 
Prevalence Study (CRISPS). Serum biomarkers including adiponectin, tumour necrosis factor-alpha R2 (TNF-α 
R2), leptin, adipocyte–fatty acid binding protein (A-FABP) and high-sensitivity C-reactive protein (hsCRP) were 
measured in baseline samples.
Results: A total of 75 participants developed diabetes over a median of 5.4 years. Low adiponectin, high A-FABP, 
hsCRP levels were, individually, significantly associated with incident diabetes after adjusting for age, sex, 
waist circumference (WC), FG, hypertension and dyslipidaemia. A backward stepwise logistic regression 
model analysing all the significant serum biomarkers showed that hypoadiponectinaemia and high A-FABP 
were independently associated with incident diabetes: OR=2.525; P=0.019; lowest versus highest quartile, for 
adiponectin and OR=2.801; P=0.022; highest versus lowest quartile, for A-FABP. Hypoadiponectinemia, but not 
A-FABP, significantly improved the log-likelihood of a clinical diabetic prediction (CDP) model including sex, 
age, WC and FG. The ROC curve showed that the CDP + adiponectin model provided a good prediction of 
diabetes (AUC=0.798; 95% CI, 0.753-0.842).
Conclusions: Our results suggested that serum levels of adiponectin, hsCRP and A-FABP were predictive of the 
development of type 2 diabetes in Chinese. Hypoadiponectinemia provides the best prediction with added 
value over traditional risk factors and is of potential use for risk assessment model development.
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